Showing 2501-2510 of 2884 results for "".
- Business News: BeautyHealth Buys SkinStylushttps://modernaesthetics.com/news/business-news-beautyhealth-buys-skinstylus/2473366/The Beauty Health Company is set to acquire SkinStylus, a US Food and Drug Adminstrayion -cleared microneedling device. The agreement represents a key step forward in BeautyHealth’s portfolio build-up strategy. Upon successful integration of SkinStylus into the BeautyHealth
- Neauvia Granted CE Marking Under the E.U.’s New MDR for Facial Dermal Filler Linehttps://modernaesthetics.com/news/neauvia-granted-ce-marking-under-the-eus-new-mdr-for-facial-dermal-filler-line/2473362/Neauvia scored CE marking under the European Union’s new MDR (Medical Device Regulation) for its range of facial dermal fillers products, making it the first medical aesthetics business to receive such certification in Europe. The new regulation aims to create ‘a robus
- CoolHealth Rolls Out TargetCool for Post-Procedure Pain Controlhttps://modernaesthetics.com/news/coolhealth-rolls-out-targetcool-for-post-procedure-pain-controlmo/2473359/CoolHealth is entering the U.S. market with TargetCool. Leveraging tuneable cooling technology, TargetCool rapidly cools the skin, allowing providers to specifically set a “target” skin temperature down to the exact degree and secon
- Industry Vet Crystal Muilenburg Joins Elevai’s Board of Directorshttps://modernaesthetics.com/news/industry-vet-crystal-muilenburg-joins-elevais-board-of-directors/2473357/Crystal Muilenburg is the newest member of Elevai’s Board of Directors. A former Evolus and Allergan executive, Muilenburg will play a key role in supporting the Elevai management team as it commercializes Elevai’s flagship exosome product line while driving t
- Dermalogica Releases Course on Treating Melanin-Rich Skinhttps://modernaesthetics.com/news/dermalogica-releases-course-on-treating-melanin-rich-skin-1/2473350/In a move to address under-representation in the professional skin care industry’s training curricula regarding melanin-rich skin tones (specifically those categorized as Fitzpatrick levels IV-VI), Dermalogica announced it is launching “Treating Melanin-Rich Skin.” <
- Game Change: Galderma Launches FACE by Galdermahttps://modernaesthetics.com/news/galderma-launches-face-by-galderma/2473349/Galderma is launching FACE by Galderma, an app that simulates the results of injectable treatments in real time using digital facial assessment. The technology was unveiled at the International Master Course on Aging Science (IMCAS) World Congress 2023 in Paris. FACE by Galder
- Study: Jeuveau “Extra-Strength” Dose Shows Lasting Resultshttps://modernaesthetics.com/news/evolus-to-present-phase-2-interim-data-from-jeuveau-extra-strength-dose-for-extended-duration-study-at-2023-imcas-world-congress/2473346/Evolus' Jeuveau Extra-Strength achieved one-point improvement on the Glabellar Lines Scale with the duration of effect lasting 26 weeks, representing a prolonged 6-month performance, the Company reports. The extra-strength glabellar line study is a multicenter, double
- Juvederm Volux XC for Jaw Definition Is Herehttps://modernaesthetics.com/news/juvederm-volux-xc-for-jaw-definition-is-here/2473344/Allergan Aesthetics' Juvéderm Volux XC is now available at aesthetic practices nationwide. The filler is approved for patients older than 21 with moderate to severe loss of jawline definition. "With 40% of aesthetically-aware consumers considering tre
- ISAPS 2021 Data: U.S. Is Plastic Surgery Capital of the Worldhttps://modernaesthetics.com/news/isaps-2021-data-us-is-plastic-surgery-capital-of-the-world/2473343/And the winner is … the USA. Plastic surgeons in the U.S, performed the most plastic surgery procedures worldwide (24.1% of the total), with 30.4 percent of all non-surgical procedures and 15.5 percent of all surgical procedures in 2021, according to the
- U.S. FDA Gives Nod to Sofwave’s SUPERB Technology for Cellulite Improvementhttps://modernaesthetics.com/news/us-fda-gives-nod-to-sofwaves-superb-technology-for-cellulite-improvement/2473342/Sofwave’s SUPERB technology is now US Food and Drug Administration (FDA)-cleared to improve the appearance of cellulite. SUPERB (Synchronous Ultrasound Parallel Beam) technology employs cooled transducers that are directly coupled to the epidermis, creating a unique